Found: 18
Select item for more details and to access through your institution.
Continuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 545, doi. 10.1111/dom.14898
- By:
- Publication type:
- Article
iGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 68, doi. 10.1111/dom.14844
- By:
- Publication type:
- Article
Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2364, doi. 10.1111/dom.14822
- By:
- Publication type:
- Article
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1221, doi. 10.1111/dom.14354
- By:
- Publication type:
- Article
Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia.
- Published in:
- European Journal of Endocrinology, 2012, v. 167, n. 4, p. 499, doi. 10.1530/EJE-12-0454
- By:
- Publication type:
- Article
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS.
- Published in:
- Addiction, 2011, v. 106, n. 4, p. 833, doi. 10.1111/j.1360-0443.2010.03306.x
- By:
- Publication type:
- Article
Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 6, p. 1187, doi. 10.1007/s13300-022-01266-4
- By:
- Publication type:
- Article
Impact of antiphosholipid biology in maternal Down syndrome screening.
- Published in:
- Prenatal Diagnosis, 2009, v. 29, n. 5, p. 481, doi. 10.1002/pd.2227
- By:
- Publication type:
- Article
Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE).
- Published in:
- Oncology, 2018, v. 94, n. 1, p. 55, doi. 10.1159/000480702
- By:
- Publication type:
- Article
Brain dynamic neurochemical changes in dystonic patients: A magnetic resonance spectroscopy study.
- Published in:
- Movement Disorders, 2013, v. 28, n. 2, p. 201, doi. 10.1002/mds.25279
- By:
- Publication type:
- Article
Depression comorbidity in spinocerebellar ataxia.
- Published in:
- Movement Disorders, 2011, v. 26, n. 5, p. 870, doi. 10.1002/mds.23698
- By:
- Publication type:
- Article
Self-rated health status in spinocerebellar ataxia-Results from a European multicenter study.
- Published in:
- Movement Disorders, 2010, v. 25, n. 5, p. 587, doi. 10.1002/mds.22740
- By:
- Publication type:
- Article
194-OR: Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Older Adults (≥70 Years) with Type 2 Diabetes (T2DM): A Subgroup Analysis of the ATOS Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-194-OR
- By:
- Publication type:
- Article
747-P: Improved Treatment Perceptions with IGlarLixi vs. Premix Insulin in Type 2 Diabetes (T2D) Uncontrolled on Basal Insulin (BI) + Oral Antihyperglycemic Drugs (OADs): Patient-Reported Outcomes (PROs) of the SoliMix Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-747-P
- By:
- Publication type:
- Article
745-P: Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Insulin-Naïve People with Type 2 Diabetes (T2DM): ATOS Study Subgroup Analysis by Baseline (BL) HbA1c.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-745-P
- By:
- Publication type:
- Article
743-P: Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Insulin-Naïve People with Type 2 Diabetes (T2DM) and Renal Impairment (RI): A Subgroup Analysis of the ATOS Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-743-P
- By:
- Publication type:
- Article
1028-P: Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (gla-300) in Insulin-Naïve Patients with Type 2 Diabetes (T2DM): Interim Analysis of the ATOS Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1028-P
- By:
- Publication type:
- Article